EFFECTS OF HO-1 ON DOPAMINERGIC NEURONS IN MODEL MOUSE OF PARKINSON DISEASE
Junxia Xie
Abstract
Junxia Xie
Abstract
Objective To investigate the effect of inhibition of heme oxgenase-1(HO-1) on dopaminergic neurons in the substantia nigra(SN) in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)-induced mouse model of Parkionson disease.Methods C57BL / 6mice were divided into three groups(control group,MPTP group and ZnPPIX+MPTP group) in random,with six in each group.A mouse model of Parkinson ’ s disease was created by i.p.injection of MPTP(30mg / kg.),once daily for five days.The mice in the MPTP group were given normal saline(2 μ L,i.c.v.) 4hbefore MPTP injection-for eight days;those in ZnPPIX+MPTP group,microinjection of ZnPPIX(50 μ g / kg) was given,4hbefore the injection of MPTP,for eight days;for those in the control,MPTP and ZnPPIX were replaced by normal saline.The expression of HO-1and TH in the SN was assessed by western blots.Results The expression of HO-1in mouse SN of ZnPPIX+MPTP was lower than that of the control group and MPTP group(F=6.844;q=5.943,4.444;P0.05).In MPTP group and ZnPPIX+MPTP group,the TH expression in SN area was lower than that in the control(F=5.095;q=4.303,4.030;P0.05),the difference of TH expression between ZnPPIX +MPTP and MPTP group was not significant(q=0.234,P0.05).Conclusion Inhibiting the expression of HO-1does not play a significant role in deteriorating the degeneration of dopaminergic neurons of Parkinson ’ s mouse induced by MPTP.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the effect of inhibition of heme oxgenase-1(HO-1) on dopaminergic neurons in the substantia nigra(SN) in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)-induced mouse model of Parkionson disease.Methods C57BL / 6mice were divided into three groups(control group,MPTP group and ZnPPIX+MPTP group) in random,with six in each group.A mouse model of Parkinson ’ s disease was created by i.p.injection of MPTP(30mg / kg.),once daily for five days.The mice in the MPTP group were given normal saline(2 μ L,i.c.v.) 4hbefore MPTP injection-for eight days;those in ZnPPIX+MPTP group,microinjection of ZnPPIX(50 μ g / kg) was given,4hbefore the injection of MPTP,for eight days;for those in the control,MPTP and ZnPPIX were replaced by normal saline.The expression of HO-1and TH in the SN was assessed by western blots.Results The expression of HO-1in mouse SN of ZnPPIX+MPTP was lower than that of the control group and MPTP group(F=6.844;q=5.943,4.444;P0.05).In MPTP group and ZnPPIX+MPTP group,the TH expression in SN area was lower than that in the control(F=5.095;q=4.303,4.030;P0.05),the difference of TH expression between ZnPPIX +MPTP and MPTP group was not significant(q=0.234,P0.05).Conclusion Inhibiting the expression of HO-1does not play a significant role in deteriorating the degeneration of dopaminergic neurons of Parkinson ’ s mouse induced by MPTP.
Key concepts: MPTP, Dopaminergic, Parkinson's disease, Substantia nigra, Chemistry, Pharmacology, Internal medicine, Endocrinology